1558 related articles for article (PubMed ID: 16437455)
1. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Ballard C; Waite J
Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
[TBL] [Abstract][Full Text] [Related]
2. Risperidone versus other atypical antipsychotics for schizophrenia.
Komossa K; Rummel-Kluge C; Schwarz S; Schmid F; Hunger H; Kissling W; Leucht S
Cochrane Database Syst Rev; 2011 Jan; (1):CD006626. PubMed ID: 21249678
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine versus other atypical antipsychotics for schizophrenia.
Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
[TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
5. Clozapine versus other atypical antipsychotics for schizophrenia.
Asenjo Lobos C; Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Leucht S
Cochrane Database Syst Rev; 2010 Nov; (11):CD006633. PubMed ID: 21069690
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.
Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.
Schneider LS; Dagerman K; Insel PS
Am J Geriatr Psychiatry; 2006 Mar; 14(3):191-210. PubMed ID: 16505124
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine versus other atypical antipsychotics for schizophrenia.
Komossa K; Rummel-Kluge C; Schmid F; Hunger H; Schwarz S; Srisurapanont M; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Jan; (1):CD006625. PubMed ID: 20091600
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole versus other atypical antipsychotics for schizophrenia.
Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
[TBL] [Abstract][Full Text] [Related]
12. Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.
Aupperle P
Am J Alzheimers Dis Other Demen; 2006; 21(2):101-8. PubMed ID: 16634465
[TBL] [Abstract][Full Text] [Related]
13. Ziprasidone versus other atypical antipsychotics for schizophrenia.
Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; Bhoopathi PS; Kissling W; Leucht S
Cochrane Database Syst Rev; 2009 Oct; (4):CD006627. PubMed ID: 19821380
[TBL] [Abstract][Full Text] [Related]
14. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008559. PubMed ID: 28791693
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of atypical antipsychotics in elderly patients with dementia.
Tariot PN; Profenno LA; Ismail MS
J Clin Psychiatry; 2004; 65 Suppl 11():11-5. PubMed ID: 15264966
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotics for delirium.
Lonergan E; Britton AM; Luxenberg J; Wyller T
Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
[TBL] [Abstract][Full Text] [Related]
18. Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.
Sultzer DL; Davis SM; Tariot PN; Dagerman KS; Lebowitz BD; Lyketsos CG; Rosenheck RA; Hsiao JK; Lieberman JA; Schneider LS;
Am J Psychiatry; 2008 Jul; 165(7):844-54. PubMed ID: 18519523
[TBL] [Abstract][Full Text] [Related]
19. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
20. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
Ostinelli EG; Hussein M; Ahmed U; Rehman FU; Miramontes K; Adams CE
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009412. PubMed ID: 29634083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]